Unimpressive short piece, but still somethingThis "Simpy Wall Street" which pumps out voluminous "stuff" every day. But still, decent summary for any newbie to get started at looking at the company
Overview: Microbix Biosystems Inc. is a life science company that develops and commercializes proprietary biological and technological solutions for human health across North America, Europe, and internationally, with a market cap of CA$55.59 million.
Operations: The company's revenue is primarily derived from its Antigens, QAPs, and DxTM segment, which generated CA$21.31 million.
Market Cap: CA$55.59M
Microbix Biosystems Inc., with a market cap of CA$55.59 million, has demonstrated significant revenue growth, reporting CA$25.39 million for the fiscal year ended September 2024, up from CA$16.51 million the previous year. The company has become profitable, posting a net income of CA$3.52 million compared to a loss in the prior year. Its financial health is bolstered by short-term assets exceeding liabilities and more cash than debt, with interest well covered by EBIT (16.7x). Recent strategic alliances and regulatory achievements in Europe further position Microbix for continued growth across its business lines.
https://finance.yahoo.com/news/discover-3-tsx-penny-stocks-141235244.html